Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemospan vs Voluven in CCLI
NCT00633659Phase 2Completed
- Sponsor
- Sangart
- Start
- Sep 2007
- Primary completion
- Jun 2008
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Hemospan in critical limb ischemia (CLI), sponsored by Sangart. Started Sep 2007; status: completed.
02
Drugs
Hemospan
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT00633659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00633659.